81 related articles for article (PubMed ID: 8388160)
41. PREVALENCE AND ASSOCIATED CHARACTERISTICS OF CYTOMEGALOVIRUS (CMV) IMMUNOGLOBULIN ANTIBODIES AMONG BLOOD DONORS AT A UNIVERSITY TEACHING HOSPITAL IN NIGERIA.
Bolarinwa RA; Donbraye E; Ademosu AA; Salawu L
East Afr Med J; 2014 Nov; 91(11):385-90. PubMed ID: 26866086
[TBL] [Abstract][Full Text] [Related]
42. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels.
Prince HE; Leber AL
Clin Diagn Lab Immunol; 2002 Jul; 9(4):824-7. PubMed ID: 12093680
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of three commercial enzyme immunoassays for toxoplasma and cytomegalovirus antibodies.
Van Enk RA; James KK; Thompson KD
Am J Clin Pathol; 1991 Mar; 95(3):428-34. PubMed ID: 1847580
[TBL] [Abstract][Full Text] [Related]
44. Cytomegalovirus antibody detection by three commercially available assays and complement fixation.
Mayo DR; Brennan T; Sirpenski SP; Seymour C
Diagn Microbiol Infect Dis; 1985 Sep; 3(5):455-9. PubMed ID: 2992868
[TBL] [Abstract][Full Text] [Related]
45. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
Just-Nübling G; Korn S; Ludwig B; Stephan C; Doerr HW; Preiser W
Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
[TBL] [Abstract][Full Text] [Related]
46. Congenital CMV infection; diagnosis in symptomatic infants.
Gandhoke I; Aggarwal R; Hussain SA; Pasha ST; Sethi P; Thakur S; Lal S; Khare S
Indian J Med Microbiol; 2009; 27(3):222-5. PubMed ID: 19584502
[TBL] [Abstract][Full Text] [Related]
47. Rubella and cytomegalovirus (CMV) infections: laboratory aspects of investigation of antenatal, congenital, persistent, and subclinical infections.
Hossain A; Bakir TM
J Trop Pediatr; 1989 Oct; 35(5):225-9. PubMed ID: 2555534
[TBL] [Abstract][Full Text] [Related]
48. Seroprevalence, transmission, and associated factors of specific antibodies against cytomegalovirus among pregnant women and their infants in a regional study.
Erfanianahmadpoor M; Nasiri R; Vakili R; Hassannia T
Saudi Med J; 2014 Apr; 35(4):360-4. PubMed ID: 24749132
[TBL] [Abstract][Full Text] [Related]
49. [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].
Ataman S; Colak D; Günseren F; Senol Y; Colak T; Aktekin MR; Gültekin M
Mikrobiyol Bul; 2007 Oct; 41(4):545-55. PubMed ID: 18173073
[TBL] [Abstract][Full Text] [Related]
50. Cytomegalovirus Infection among Pregnant Women in Beijing: Seroepidemiological Survey and Intrauterine Transmissions.
Jin Q; Su J; Wu S
J Microbiol Biotechnol; 2017 May; 27(5):1005-1009. PubMed ID: 28285497
[TBL] [Abstract][Full Text] [Related]
51. Comparison of a latex agglutination test with five other methods for determining the presence of antibody against cytomegalovirus.
Beckwith DG; Halstead DC; Alpaugh K; Schweder A; Blount-Fronefield DA; Toth K
J Clin Microbiol; 1985 Mar; 21(3):328-31. PubMed ID: 2984241
[TBL] [Abstract][Full Text] [Related]
52. Rapid detection of anti-OKT3 antibodies with the Transtat assay.
Schroeder TJ; First MR; Pouletty C; Hariharan S; Pouletty P
Transplantation; 1993 Feb; 55(2):297-9. PubMed ID: 8434379
[TBL] [Abstract][Full Text] [Related]
53. Placental transfer of naturally acquired, maternal cytomegalovirus antibodies in term and preterm neonates.
Mussi-Pinhata MM; Pinto PC; Yamamoto AY; Berencsi K; de Souza CB; Andrea M; Duarte G; Jorge SM
J Med Virol; 2003 Feb; 69(2):232-9. PubMed ID: 12683413
[TBL] [Abstract][Full Text] [Related]
54. Re-evaluation of the VIDAS(®) cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation.
Vauloup-Fellous C; Berth M; Heskia F; Dugua JM; Grangeot-Keros L
J Clin Virol; 2013 Feb; 56(2):118-23. PubMed ID: 23182774
[TBL] [Abstract][Full Text] [Related]
55. Latex enzyme immunoassay for measuring IgG antibodies to rubella virus.
Duverlie G; Roussel C; Driencourt M; Orfila J
J Clin Pathol; 1990 Sep; 43(9):766-70. PubMed ID: 2212070
[TBL] [Abstract][Full Text] [Related]
56. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
Dangel V; Bäder U; Enders G
J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
[TBL] [Abstract][Full Text] [Related]
57. Large-scale testing of human serum to determine cytomegalovirus neutralising antibody.
Leogrande G; Merchionne F; Lazzarotto T; Landini MP
J Infect; 1992 May; 24(3):289-99. PubMed ID: 1318340
[TBL] [Abstract][Full Text] [Related]
58. Measurement and assessment of cytomegalovirus of immunoglobulin (Ig) g titer in preparations.
Shibaguchi H; Yamamoto T; Kuroki M; Futagami K
Yakugaku Zasshi; 2010 Jul; 130(7):977-82. PubMed ID: 20606378
[TBL] [Abstract][Full Text] [Related]
59. Comparison of four techniques for detection of antibodies to cytomegalovirus.
Kraat YJ; Hendrix RM; Landini MP; Bruggeman CA
J Clin Microbiol; 1992 Feb; 30(2):522-4. PubMed ID: 1311337
[TBL] [Abstract][Full Text] [Related]
60. A comparison of four commercial test kits for detection of cytomegalovirus antibodies in blood donors.
Feng CS; Williams IB; Gohd RS; Causey AP
Transfusion; 1986; 26(2):203-4. PubMed ID: 3006300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
